[go: up one dir, main page]

MX2012012559A - Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo. - Google Patents

Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo.

Info

Publication number
MX2012012559A
MX2012012559A MX2012012559A MX2012012559A MX2012012559A MX 2012012559 A MX2012012559 A MX 2012012559A MX 2012012559 A MX2012012559 A MX 2012012559A MX 2012012559 A MX2012012559 A MX 2012012559A MX 2012012559 A MX2012012559 A MX 2012012559A
Authority
MX
Mexico
Prior art keywords
dopamine
composition
tio2
brain
hemiparkinsonism
Prior art date
Application number
MX2012012559A
Other languages
English (en)
Inventor
Patricia Vergara Aragon
María Guadalupe Valverde Aguilar
Jorge Alfonso Garcia Macedo
Original Assignee
Patricia Vergara Aragon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patricia Vergara Aragon filed Critical Patricia Vergara Aragon
Priority to MX2012012559A priority Critical patent/MX2012012559A/es
Publication of MX2012012559A publication Critical patent/MX2012012559A/es

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composición de TiO2/Dopamina preparado por el método sol-gel con nanoporos que contienen a la dopamina y la protegen de oxidación por luz y aire que la dañarían impidiendo su efecto como neurotransmisor en el cerebro. La liberación constante de la dopamina desde el composición permite un control de los síntomas del Mal de Parkinson.
MX2012012559A 2012-10-29 2012-10-29 Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo. MX2012012559A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2012012559A MX2012012559A (es) 2012-10-29 2012-10-29 Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012012559A MX2012012559A (es) 2012-10-29 2012-10-29 Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo.

Publications (1)

Publication Number Publication Date
MX2012012559A true MX2012012559A (es) 2014-04-28

Family

ID=51213264

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012012559A MX2012012559A (es) 2012-10-29 2012-10-29 Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo.

Country Status (1)

Country Link
MX (1) MX2012012559A (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015173258A1 (en) * 2014-05-13 2015-11-19 Centre Hospitalier Regional Et Universitaire De Lille (Chru) Pharmaceutical solution comprising dopamine for use in treating parkinson's disease
WO2024056749A1 (en) 2022-09-14 2024-03-21 Inbrain Pharma Pharmaceutical injectable solution comprising dopamine

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015173258A1 (en) * 2014-05-13 2015-11-19 Centre Hospitalier Regional Et Universitaire De Lille (Chru) Pharmaceutical solution comprising dopamine for use in treating parkinson's disease
US10105326B2 (en) 2014-05-13 2018-10-23 Centre Hospitalier Regional Et Universitaire De Lille (Chru) Pharmaceutical solution comprising dopamine for use in treating parkinson's disease
EP3453388A1 (en) 2014-05-13 2019-03-13 Centre Hospitalier Régional et Universitaire de Lille Pharmaceutical solution comprising dopamine hydrochloride
AU2015260953B2 (en) * 2014-05-13 2020-02-27 Centre Hospitalier Regional Et Universitaire De Lille (Chru) Pharmaceutical solution comprising dopamine for use in treating Parkinson's disease
WO2024056749A1 (en) 2022-09-14 2024-03-21 Inbrain Pharma Pharmaceutical injectable solution comprising dopamine

Similar Documents

Publication Publication Date Title
IL267997A (en) Preparations, formulations and methods for treating eye diseases
HUE038664T2 (hu) Hialuronsav C6-C18-acilezett származéka, eljárás annak elõállítására, erre épülõ nanomicelláris kompozíció, eljárás annak elõállítására és eljárás stabilizált nanomicelláris kompozíció elõállítására, valamint annak alkalmazása
ZA201503110B (en) Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
EP2931288A4 (en) TOPICAL FORMULATIONS FOR INCREASING THE DERMAL CONCENTRATION OF HYALURONIC ACID
MY179194A (en) Process for preparing therapeutic nanoparticles
HK1206393A1 (en) Compositions and methods for diagnosis and treatment of pervasive developmental disorder
CL2014003165A1 (es) Proceso mejorado para la preparación de treprostinil y derivados del mismo.
PL2882779T3 (pl) Pochodna kwasu hialuronowego, sposób jej wytwarzania, sposób jej modyfikacji i jej zastosowanie
SG11201404728VA (en) Nanoparticle paste formulations and methods for production and use thereof
ZA201401613B (en) Method for producing highly pure platinum powder, as well as platinum powder that can be obtained according to said method, and use thereof
IN2015DN00924A (es)
GB2518801B (en) Improvements in, or relating to, caskets or coffins
IL236637A0 (en) Difluorolactam compounds as selective ep4 receptor agonists for use in the treatment of ep4-mediated conditions and diseases
IL234606A0 (en) Innovative methods and compounds for the treatment of diseases
DOP2015000007A (es) Métodos para preparar triazolopiridinas sutituidas
WO2013038195A3 (en) Pharmaceutical nanoparticle compositions
MX2012012559A (es) Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo.
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
MX2013007331A (es) Composicion de tio2/15c5/dopamina insertada en el cerebro de la rata para el tratamiento de hemiparkinsonismo.
EP2847161A4 (en) COMPOSITIONS AND METHODS FOR TREATING DIABETES
PL399613A1 (pl) Pochodne estrów diarylowych kwasów 1-aminoalkanofosfonowych, sposób wytwarzania pochodnych estrów diarylowych kwasów 1-aminoalkanofosfonowych oraz ich zastosowanie
MX351994B (es) Formas cristalinas de [(s)-1-carbamoil-2-(feniil-pirimidin-2-il-am ino)-etil]-amida del acido 2-(2-metilamino-pirimidin-4-il)-1h-indo l-5-carboxilico.
Yang et al. Compositions and methods for increasing cellulose production
IN2012CH02984A (es)
Barcellos et al. Survivorship of Pinus Taeda Exposed to Benzene-Based Compounds: Preliminary Study to Support Phytoremediation Greenhouse Experiment.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal